Synchronous inhibition of mTOR and VEGF/NRP1 axis impedes tumor growth and metastasis in renal cancer
Krishnendu Pal(Jacksonville College), Debabrata Mukhopadhyay(Jacksonville College), Vijay Sagar Madamsetty(Jacksonville College), Ramcharan Singh Angom(Mayo Clinic in Arizona), Enfeng Wang(Jacksonville College), Shamit K. Dutta(WinnMed)
Cited by 47
Related Papers
In vivo gene delivery mediated by non-viral vectors for cancer therapy
|Journal of Controlled Release|2020|240
Recent Trends of the Bio-Inspired Nanoparticles in Cancer Theranostics
|Frontiers in Pharmacology|2019|210
Dexamethasone: Insights into Pharmacological Aspects, Therapeutic Mechanisms, and Delivery Systems
|ACS Biomaterials Science & Engineering|2022|174
Activation of Sp1-mediated Vascular Permeability Factor/Vascular Endothelial Growth Factor Transcription Requires Specific Interaction with Protein Kinase C ζ
|Journal of Biological Chemistry|1998|164
Recent Advancements of Nanomedicine in Neurodegenerative Disorders Theranostics
|Advanced Functional Materials|2020|153